See also the reduction wave. Nearly a half months, including Jiangsu, Wu, Southwest medicine, Meiluoyaoye, Jiaying including a number of pharmaceutical companies such as pharmaceutical companies have encountered substantial stock holdings.digital blood pressure monitor And just on April 20 at the Hong Kong-listed Tailing medicine, only 9 days in the market was 230 million shares of Goldman Sachs holdings of the venue, followed only by playing several rounds of individual stocks and stock changes the game dramatically , so that the industry eyebrows.
There have been similar to the situation of medical devices in medical Dunlop. Reduction in the general manager of madness, the company's largest shareholder BROOK sit still in circulation, from the year March 23 to May 26 by the Shenzhen Stock Exchange accumulated large holdings of 1,000 shares trading system. May in the May 31,digital thermometer manufacturer the controlling shareholder of a sudden way to buy holdings of A shares of 3,108.5 million shares, and promised to continue in the secondary market within a year holdings.
Reduction of wind underway
Capital flows from the point of view, both the Shanghai and Shenzhen show the main net outflow of funds the state. digital thermometer Among the many industries in the sector, the pharmaceutical industry the most amount of net capital outflows, reaching 441 million. The reporters found that there have been the new medicine, Ring biological, Haixiang Medicine, Jilin Medical, Pharmaceutical and other associated ring stocks holdings by large shareholders, and shares are basically to the reduction of hundreds of thousands of shares.
The concept of radiation is due to stock Meiluoyaoye stir, although the first quarter net profit jumped three times, but still Nanzu shareholders holdings will. In mid-April Meiluoyaoye announcement that the company's largest shareholders have holdings of Metro Group, the company has 800 million shares and 950 million shares, a total of 1750 million, accounting for 5% of the total share capital. Medicine stocks, Jiaying Pharmaceutical company executives have been selling after another. Sales commitments in the three years after the expiration of the original third-largest shareholder, following two months in a substantial reduction of Huang Zhiyong, the actual controller Huang Xiaobiao Jiaying Pharmaceutical also said that six months will be a substantial reduction in drug shares Jiaying .
"Pharmaceutical stocks appeared to be very 'injured', mainly with the current downturn in the domestic stock market related. Since most medical share capital is not much, and many large proportion of ownership by institutions, if the change in the attitude of investors in the company, will affect the future of enterprises. "Some analysts have begun to show disturbing. Reporters also learned that the reduction of thousands of shares surge at every turn is thrown, a lot of people in the industry are worried.
Minsheng Securities Fund, a fund manager told reporters, "After all, pharmaceutical stocks are now generally higher than the valuation, the valuation if the related stocks have been fully reflected the growth in the market downturn, the appropriate weight will reduce the number of configuration is normal . "
According to an analyst from Shanghai Peng Yunliang analysis of the pharmaceutical industry, pharmaceutical stocks frequent reduction of the current action may be encountered credit problems, funding is tight, major shareholders to sell to ease the financial pressure for enterprises rolling development. "For example, a quarterly medical care from the Dunlop can be seen, its wholly-owned subsidiary, Beijing Sida medical device company for the new series of annual output of 15 000 GK production base of artificial heart valves need to raise capital over 23 million yuan, its major shareholder Mengjin Meng also is mainly based on the above considerations. "
Therefore, the reduction of corporate finance has become a fast track. Holdings have publicly expressed intent to take away the potential there to seek medicine southwest. Southwest Pharmaceutical Co., according to a notice issued, beginning April 20, Tai Chi shares sold through the trading system, 226 million shares. Taiji Group, directly or indirectly as holding a Tai Chi Group, Tong Junge and Southwest Pharmaceutical three listed companies, and another three in the main business on the competitive relationship with the industry, making it difficult in the secondary market, Taiji Group financing.
Will not transmit
The reduction of the pharmaceutical companies were generally smaller equity, a higher proportion of institutional ownership. Such as the total share capital Jiaying Pharmaceutical 205 million shares, the top three shareholders hold 57.2% stake; and the total medical Dunlop 812 million equity shares will, but the top three shareholders in the stock was as high as 65.4%. Reduction of frequently encountered sustained development of these companies has brought uncertainty. But the reporter analysis of these stocks, they found an entirely different story: that the reduction in the major shareholders have the same time, pharmaceutical companies have been selling performance on the secondary market, investors continued to transfer confidence.
This reporter learned that more than two years after the listing has been no dividend Jiaying Pharma, but in 2010 mid-year report and annual report were carried out after a large proportion of dividends. Mid-2010 to all shareholders get 3 shares for every 10 shares 7 shares increase by transferring and send 1 million, again in 2010 Annual Report sent to 2.5 shares for every 10 shares and sent the 0.5 yuan. In the first quarter, the company attributable to shareholders of listed companies net profit rose 75.06%. Have started in the holdings of major shareholders, while the performance is Jiaying Pharmaceutical enough confidence to bring to market.